Trial intelligence / Profile preview

Dose-ranging cineole study in severe acute bronchitis

2017-003044-20Phase 2Completed

Sponsor
Cassella-med
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of eucalyptol in acute bronchitis and nasopharyngitis (4 arms), sponsored by Cassella-med. Primary endpoint: Primary efficacy endpoint. Started Aug 2017; status: completed.

02

Drugs

eucalyptol
03

Conditions

acute bronchitisnasopharyngitis

Beyond the preview

Go deeper on 2017-003044-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003044-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call